Literature DB >> 15837543

HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.

Paola Parrella1, Marina Scintu, Maria Prencipe, Maria Luana Poeta, Antonietta Pia Gallo, Carla Rabitti, Monica Rinaldi, Stefania Tommasi, Angelo Paradiso, Francesco Schittulli, Vanna Maria Valori, Salvatore Toma, Vittorio Altomare, Vito Michele Fazio.   

Abstract

The HIC1 gene is a transcriptional regulator commonly methylated in a variety of human cancer. Thirty-three invasive ductal carcinomas of the breast and 21 matched normal breast tissues were analysed for HIC1 promoter methylation, and allelic loss of a 700 kb region spanning the gene locus. At least one genetic or epigenetic abnormality was found in 27 of the carcinomas tested (82%). Promoter methylation was demonstrated in 21 carcinomas (64%), and nine normal tissues (43%), whereas 18 malignant tumors (54%) showed allelic loss. Concomitant loss of heterozigosity and promoter hypermethylation in the region spanning HIC1 was detected in eight carcinomas (24%) suggesting that in this subset of tumors both copies of the gene are functionally lost. These observations support a role for the HIC1 gene in the pathogenesis of breast ductal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837543     DOI: 10.1016/j.canlet.2004.08.026

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.

Authors:  Gaylor Boulay; Nicolas Malaquin; Ingrid Loison; Bénédicte Foveau; Capucine Van Rechem; Brian R Rood; Albin Pourtier; Dominique Leprince
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

2.  P53 induction accompanying G2/M arrest upon knockdown of tumor suppressor HIC1 in U87MG glioma cells.

Authors:  Sanjay Kumar
Journal:  Mol Cell Biochem       Date:  2014-07-04       Impact factor: 3.396

3.  Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.

Authors:  Ruo-Chia Tseng; Chin-Chu Lee; Han-Shui Hsu; Ching Tzao; Yi-Ching Wang
Journal:  Neoplasia       Date:  2009-08       Impact factor: 5.715

4.  Small activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancer.

Authors:  Feng Zhao; Shengli Pan; Yan Gu; Shanyu Guo; Qiancheng Dai; Yingyan Yu; Wei Zhang
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

5.  Reactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells.

Authors:  Feng Zhao; Shengli Pan; Yan Gu; Shanyu Guo; Qiancheng Dai; Yingyan Yu; Wei Zhang
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

6.  Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.

Authors:  Xiumin Wang; Yingying Wang; Gang Xiao; Jinglong Wang; Lidong Zu; Mingang Hao; Xueqing Sun; Yujie Fu; Guohong Hu; Jianhua Wang
Journal:  Oncotarget       Date:  2016-05-24

7.  Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma.

Authors:  Wenyi Wu; Liting Zhang; Jianqing Lin; Hanwei Huang; Bai Shi; Xingong Lin; Zhongxin Huang; Chaoyang Wang; Jianlong Qiu; Xiaolong Wei
Journal:  Oncotarget       Date:  2016-12-20

8.  Association between HIC1 promoter methylation and solid tumor: A meta-analysis.

Authors:  Tie Zhao; Justice Afrifa; Dong Wang; Jingcui Yu
Journal:  EXCLI J       Date:  2020-04-07       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.